Clinical pharmacokinetics in patients with spinal cord injuries

JL Segal, SR Brunnemann - Clinical pharmacokinetics, 1989 - Springer
Although spinal cord injury is a catastrophic affliction with numerous victims and a variety of
physiological manifestations, the associated disarray in physiology has yet to be …

Optimal drug therapy and therapeutic drug monitoring after spinal cord injury: a population-specific approach

JL Segal, MS Pathak - American Journal of Therapeutics, 2001 - journals.lww.com
Survival after spinal cord injury (SCI), once measured in terms of weeks or months, is now
measured in years, and most survivors of SCI go on to live full lives. The quality of life …

Spinal cord injury sequelae alter drug pharmacokinetics: an overview

H Mestre, T Alkon, S Salazar, A Ibarra - Spinal cord, 2011 - nature.com
Study design: Literature review. Objectives: Critical review of the literature published on the
physiological alterations caused by spinal cord injury (SCI) and their effect on the …

Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously

P García-López, A Martínez-Cruz, G Guízar-Sahagún… - Spinal cord, 2007 - nature.com
Study design: Experimental laboratory investigations in paraplegic rats. Objective: In order to
understand why acute spinal cord injury (SCI) changes the disposition of some, but not all …

Importance of pharmacologic considerations in the evaluation of new treatments for acute spinal cord injury

ED HALL - Journal of Neurotrauma, 1992 - liebertpub.com
DISCUSSION Dr. Tator: Could you comment on ways to get pharmacokinetics data for a
given drug? You mentioned HPLC for plasma and tissue drug levels. What about …

Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord

KA Greene, FF Marciano, VKH Sonntag - Clinical Spine Surgery, 1996 - journals.lww.com
Spinal cord injury often results in devastating physical, psychological, and economic
disabilities. Research efforts are directed toward providing prognostic outcome data and …

The absolute bioavailability of oral theophylline in patients with spinal cord injury

JL Segal, SR Brunnemann, SK Gordon… - … : The Journal of …, 1986 - Wiley Online Library
The absolute bioavailability of oral theophylline in five tetraplegic, five paraplegic and three
control (intact neuraxes) subjects was studied. All were healthy nonobese males between …

Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury

JL Segal, SR Brunnemann… - Drug intelligence & …, 1988 - journals.sagepub.com
The rate and completeness of absorption of gentamicin from muscle (healthy and paralyzed)
and gentamicin disposition kinetics following a single intravenous infusion were studied in …

Pharmacological approaches to chronic spinal cord injury

I Steuer, P Rouleau, PA Guertin - Current pharmaceutical …, 2013 - ingentaconnect.com
Although research on neural tissue repair has made enormous progress in recent years,
spinal cord injury remains a devastating condition for which there is still no cure. In fact …

Decreased systemic clearance of lorazepam in humans with spinal cord injury

JL Segal, SR Brunnemann, IM Eltorai… - The Journal of Clinical …, 1991 - Wiley Online Library
Serum concentration‐time course profiles, serum protein binding, and disposition
parameters of lorazepam (LRZ), a benzodiazepine with sedative‐hypnotic, anxiolytic, and …